These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 31875166)
21. Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis. Wilson R; Aksamit T; Aliberti S; De Soyza A; Elborn JS; Goeminne P; Hill AT; Menendez R; Polverino E Respir Med; 2016 Aug; 117():179-89. PubMed ID: 27492530 [TBL] [Abstract][Full Text] [Related]
22. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis. Smith S; Rowbotham NJ; Charbek E Cochrane Database Syst Rev; 2018 Oct; 10(10):CD008319. PubMed ID: 30376155 [TBL] [Abstract][Full Text] [Related]
23. A review of non-cystic fibrosis bronchiectasis in children with a focus on the role of long-term treatment with macrolides. El Boustany P; Gachelin E; Colomban C; Cernoia J; Sudour P; Carsin A; Dubus JC Pediatr Pulmonol; 2019 Apr; 54(4):487-496. PubMed ID: 30652424 [TBL] [Abstract][Full Text] [Related]
24. Long-term antibiotic treatment for non-cystic fibrosis bronchiectasis in adults: evidence, current practice and future use. Goldman N; Loebinger MR; Wilson R Expert Rev Respir Med; 2016 Dec; 10(12):1259-1268. PubMed ID: 27820964 [TBL] [Abstract][Full Text] [Related]
25. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. Langton Hewer SC; Smith S; Rowbotham NJ; Yule A; Smyth AR Cochrane Database Syst Rev; 2023 Jun; 6(6):CD004197. PubMed ID: 37268599 [TBL] [Abstract][Full Text] [Related]
26. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)]. ; ; Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959 [TBL] [Abstract][Full Text] [Related]
27. Self-management for bronchiectasis. Kelly C; Grundy S; Lynes D; Evans DJ; Gudur S; Milan SJ; Spencer S Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012528. PubMed ID: 29411860 [TBL] [Abstract][Full Text] [Related]
28. Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT. Langton Hewer SC; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Sutton L; Clayton D; Arch B; Tanajewski Ł; Berdunov V; Williamson PR Health Technol Assess; 2021 Nov; 25(65):1-128. PubMed ID: 34806975 [TBL] [Abstract][Full Text] [Related]
29. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis. Ryan G; Jahnke N; Remmington T Cochrane Database Syst Rev; 2012 Dec; 12():CD008319. PubMed ID: 23235659 [TBL] [Abstract][Full Text] [Related]
31. Meta-analysis of efficacy and safety of inhaled ciprofloxacin in non-cystic fibrosis bronchiectasis patients. Wang S; Zhang A; Yao X Intern Med J; 2021 Sep; 51(9):1505-1512. PubMed ID: 33469994 [TBL] [Abstract][Full Text] [Related]
32. Oral versus inhaled antibiotics for bronchiectasis. Spencer S; Felix LM; Milan SJ; Normansell R; Goeminne PC; Chalmers JD; Donovan T Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012579. PubMed ID: 29587336 [TBL] [Abstract][Full Text] [Related]
33. Inhaled tobramycin for chronic infection with pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis. Sangiovanni S; Morales EI; Fernández-Trujillo L Respir Med; 2021 Jan; 176():106283. PubMed ID: 33307314 [TBL] [Abstract][Full Text] [Related]
34. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Smith S; Waters V; Jahnke N; Ratjen F Cochrane Database Syst Rev; 2020 Jun; 6(6):CD009528. PubMed ID: 32520436 [TBL] [Abstract][Full Text] [Related]
35. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Waters V; Ratjen F Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009528. PubMed ID: 28981972 [TBL] [Abstract][Full Text] [Related]
36. Non-cystic fibrosis bronchiectasis: clinical presentation, diagnosis and treatment, illustrated by data from a Dutch Teaching Hospital. Altenburg J; Wortel K; van der Werf TS; Boersma WG Neth J Med; 2015 May; 73(4):147-54. PubMed ID: 25968285 [TBL] [Abstract][Full Text] [Related]
37. Inhaled antibiotics for treatment of adults with non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis. Tejada S; Campogiani L; Solé-Lleonart C; Gómez A; Gallego M; Vendrell M; Soriano JB; Rello J Eur J Intern Med; 2021 Aug; 90():77-88. PubMed ID: 33947626 [TBL] [Abstract][Full Text] [Related]
38. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial. Bilton D; Tino G; Barker AF; Chambers DC; De Soyza A; Dupont LJ; O'Dochartaigh C; van Haren EH; Vidal LO; Welte T; Fox HG; Wu J; Charlton B; Thorax; 2014 Dec; 69(12):1073-9. PubMed ID: 25246664 [TBL] [Abstract][Full Text] [Related]
39. Clinical impact of chronic obstructive pulmonary disease on non-cystic fibrosis bronchiectasis. A study on 1,790 patients from the Spanish Bronchiectasis Historical Registry. De la Rosa D; Martínez-Garcia MA; Giron RM; Vendrell M; Olveira C; Borderias L; Maiz L; Torres A; Martinez-Moragon E; Rajas O; Casas F; Cordovilla R; de Gracia J PLoS One; 2017; 12(5):e0177931. PubMed ID: 28542286 [TBL] [Abstract][Full Text] [Related]
40. Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry. Henkle E; Aksamit TR; Barker AF; Curtis JR; Daley CL; Anne Daniels ML; DiMango A; Eden E; Fennelly K; Griffith DE; Johnson M; Knowles MR; Leitman A; Leitman P; Malanga E; Metersky ML; Noone PG; O'Donnell AE; Olivier KN; Prieto D; Salathe M; Thomashow B; Tino G; Turino G; Wisclenny S; Winthrop KL Chest; 2017 Dec; 152(6):1120-1127. PubMed ID: 28479113 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]